328400login-checkMonoclonal Antibodies Safe for Organ Recipients with Covid-19 |
Solid organ transplant recipients with mild-to-moderate Covid-19 can be safely treated with monoclonal antibody therapy, a new study confirmed.
Researchers at the Mayo Clinic, Rochester, reported that monoclonal antibody treatment was associated with favorable outcomes with minimal side effects in the first solid organ transplant patients to receive the infusions for Covid-19 at their center.
None of the 73 patients died, required mechanical ventilation, or experienced organ rejection.
Eleven of the patients (15%) had emergency department visits within 28 days of monoclonal antibody infusion, including 9 who were hospitalized for a median of 4 days. Just one patient required ICU admission for a non-Covid-19 indication.
Read more, here.
328400login-checkMonoclonal Antibodies Safe for Organ Recipients with Covid-19 |